Objective: To evaluate the impact of depth of cervical stromal invasion (CSI) on the prognosis of International Federation of Gynecology and Obstetrics (FIGO) stage II endometrioid endometrial cancer ...

She retired from active practice in Glasgow in 2021 due to commitments as CEO, International Federation Obstetrics and Gynaecology (FIGO), a global charity for ... disorders (particularly those women ...

Herein we focus on the invasive tumor front, making an in-depth characterization of reticular fiber scaffolding, infiltrating immune cells, gene expression, and epigenetic profiles of classified ...

Black women tend to get more aggressive uterine cancers than White women. But this is only part of the story, investigators ...

Clinicians should adopt a risk-based, rather than biopsy-first, approach to encourage biopsy acceptance and improve early ...

One of Australia's most common gynecological cancers could be detected sooner and more accurately thanks to a specialized artificial intelligence (AI) model, new research shows.

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to come in the future.

The following is a summary of “Facilitators and Barriers to Acceptability of a Biopsy-First Approach in the Diagnostic ...

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...

The following is a summary of “Geographic and racial disparities in the quality of surgical care among patients with ...

Combination treatment with cadonilimab and lenvatinib can produce responses in patients with advanced endometrial cancer.